Patent · US Active

Schizophrenia related protein

US7449543B2 · kind B2 · utility

1Cited by

1References

16Claims

0Family size

Assignee

Serono Genetics Institute S.A. · FR

Inventors

Bernard Bihain · Encinitas, US
Barbara Bour · San Diego, US
Lydie Bougueleret · Lancy, CH

Key dates

Filing date	Mar 30, 2007
Grant date	Nov 11, 2008
Priority date	—
Expiry date	Mar 30, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/00
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention relates to polynucleotides of the PAPAP gene, polypeptides encoded by the PAPAP gene, and antibodies directed specifically against such polypeptides. The invention also concerns methods for the treatment or diagnosis of schizophrenia, bipolar disorder or related CNS disorder. The invention also concerns the interaction of PAPAP with schizophrenia candidate gene g34872.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.